Lipid management in patients with endocrine disorders: An endocrine society clinical practice guideline

Connie B. Newman, Michael J. Blaha, Jeffrey B. Boord, Bertrand Cariou, Alan Chait, Henry G. Fein, Henry N. Ginsberg, Ira J. Goldberg, M. Hassan Murad, Savitha Subramanian, Lisa R. Tannock

Research output: Contribution to journalReview articlepeer-review

Abstract

Objective: This guideline will provide the practicing endocrinologist with an approach to the assessment and treatment of dyslipidemia in patients with endocrine diseases, with the objective of preventing cardiovascular (CV) events and triglyceride-induced pancreatitis. The guideline reviews data on dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk in patients with endocrine disorders and discusses the evidence for the correction of dyslipidemia by treatment of the endocrine disease. The guideline also addresses whether treatment of the endocrine disease reduces ASCVD risk. Conclusion: This guideline focuses on lipid and lipoprotein abnormalities associated with endocrine diseases, including diabetes mellitus, and whether treatment of the endocrine disorder improves not only the lipid abnormalities, but also CV outcomes. Based on the available evidence, recommendations are made for the assessment and management of dyslipidemia in patients with endocrine diseases.

Original languageEnglish (US)
JournalJournal of Clinical Endocrinology and Metabolism
Volume105
Issue number12
DOIs
StatePublished - Dec 1 2020

Keywords

  • Cardiovascular disease
  • Diabetes
  • Dyslipidemia
  • Endocrine diseases
  • Lipids
  • Triglycerides

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Lipid management in patients with endocrine disorders: An endocrine society clinical practice guideline'. Together they form a unique fingerprint.

Cite this